Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-02-21 @ 7:59 AM
Study NCT ID:
NCT02899169
Status:
UNKNOWN
Last Update Posted:
2021-09-08
First Post:
2016-09-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)
Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
XJTU1AF2016LSL-017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |